Determining the most effective combination of patient navigation strategies to reduce loss-to-follow-up in the cervical cancer screening pathway in Tanzania

Phase 4

• Conditions: Cancer

• Registration Number: PACTR202307605212308
• Lead Sponsor: Queens University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-08
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 1500

Inclusion Criteria

The inclusion criteria for participants is the following:
- Gender: person with an intact cervix
- Age: 25 (if HIV positive) and/or age 30 to 49 years old at the time of enrollment as reported verbally
- Residence in the study-defined catchment area
- Language: able to speak/understand English (preferred) or Kiswahili (if the participant cannot read the consent will be read to her and a thumbprint will suffice for consent)

The inclusion criteria for CHWs is the following: 60 CHWs (2 CHWs per ward for a total of 30 wards) will be selected based on the following inclusion criteria:
- Women
- Physically fit/ambulatory
- Secondary school completion (preferred)
- Can read and write in Kiswahili and ‘basic’ English
- Experience using Android smartphone/tablets (preferred)
- Can be trained to perform informed consent process

The inclusion criteria for CECAP providers is the following: 54 CECAP providers will be recruited. Inclusion criteria are:
- CECAP provider of a CECAP site in the Kilimanjaro region
- Participated in previous SEVIA training (familiar with cervical images and review process)
- Can read and write in Kiswahili and English
- Experience using technology/tablets (preferred)

Exclusion Criteria

The exclusion criteria for the women is the following:
- Current pregnancy (if verbally reported as currently pregnant or possibly pregnant)
- History of cervical cancer
- History of hysterectomy
- Unwilling to collect vaginal specimen for any reason (note that menstrual bleeding is not a contraindication if women are willing to collect the specimen while bleeding)
- Apparent inability to give informed consent
- Unwillingness to participate

Study & Design

• Study Type: Interventional
• Study Design: Not specified